PUBLICATIONS

1. 2017-Robert James Debs, Timothy D. Heath, Chakkrapong Handumrongkul, Systems and methods for nucleic acid expression in vivo, Patent No: US 2017/0080108A1.
2. 2019-Wojciech G. Lesniak, Chengyan Chu, Anna Jablonska, Yong Du, Martin G. Pomper, Piotr Walczak, and Miroslaw Janowski, A Distinct Advantage to Intraarterial Delivery of 89Zr-Bevacizumab in PET Imaging of Mice With and Without Osmotic Opening of the Blood–Brain Barrier, J Nucl Med 2019; 60:617–622.  https://doi.org/10.2967/jnumed.118.218792
3. 2019-Igor Y. Pavlova, Rebecca L. Parkera, Eszter Lazar-Molnara, Frederick G. Strathmannb, Julio C. Delgadoa , Inductively coupled plasma mass spectrometry assay for quantification of free infliximab in serum, Journal of Immunological Methods, https://doi.org/10.1016/j.jim.2019.04.008.
4. 2019-Jumpei Saito, Naho Yakuwa, Kayoko Kaneko, Ken Nakajima, Chinatsu Takai, Mikako Goto, Akimasa Yamatani, Atsuko Murashima, Clinical application of the dried milk spot method for measuring tocilizumab concentrations in the breast milk of patients with rheumatoid arthritis, Int J Rheum Dis. 2019;22:1130–1137.
5. 2020-Le VNH, Hos D, Hou Y, Witt M, Barkovskiy M, Bock F, Cursiefen C. VEGF TrapR1R2 suspended in the semifluorinated alkane F6H8 inhibits inflammatory corneal hem- and lymphangiogenesis. Trans Vis Sci Tech. 2020;9 (11):15. https://doi.org/10.1167/tvst.9.11.15
6. 2020-Hanžel J, Zdovc J, Kurent T, Sever N, Javornik K, Tuta K, Koželj M, Smrekar N, Novak G, Štabuc B, Dreesen E, Thomas D, Vovk T, Grabnar I, Drobne D, Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn’s Disease Likely to Achieve Endoscopic and Biochemical Remission, Clinical Gastroenterology and Hepatology (2020), doi: https://doi.org/10.1016/j.cgh.2020.02.033.
7. 2020-Oleksiy Buznyk, Mohammad Azharuddin, Mohammad M. Islam, Per Fagerholm, Nataliya Pasyechnikova, Hirak K. Patra, Collagen-based scaffolds with infused anti-VEGF release system as potential cornea substitute for high-risk keratoplasty: A preliminary in vitro evaluation, Heliyon 6 (2020), https://doi.org/10.1016/j.
8. 2020-Qian Wang, William Gavin, Nick Masiello, Khanh B. Tran , Gotz Laible and Peter R Shepherd, Cetuximab produced from a goat mammary gland expression system is equally efficacious as innovator cetuximab in model systems of cancer. bioRxiv doi: https://doi.org/10.1101/2020.06.04.135434.
9. 2020-Nazarov VD, Lapin SV, Tulenko KV, et al. The influence of tocilizumab immunogenicity markers on the effectiveness of treating rheumatoid arthritis. Herald of North-Western State Medical University named after I.I. Mechnikov. 2020;12(1):31‑ https://doi.org/10.17816/mechnikov33825.
10. 2020-David H. Kirn, Melissa Kotterman, David Schaffer, Paul Szymanski, Peter Francis, Adeno-associated virus variant capsid and use for inhibiting angiogenesis,Patent No : US 2020/0282077A1.
11. 2020-Hasan Selcuk Ozger, Murat Dizbay, Seref Kerem Corbacioglu, Pinar Aysert, Zehra Demirbas, Ozlem Guzel Tunccan, Kenan Hizel, Gulendam Bozdayi, Kayhan Caglar, The prognostic role of neopterin in COVID‐19 patients, J Med Virol. 2020;1–6,DOI: 10.1002/jmv.26472.
12. 2021-Jurij Hanžel, Matic Koželj, Ana Špes Hlastec, Tina Kurent, Nejc Sever, Jurij Zdovc, Nataša Smrekar, Gregor Novak, Borut Štabuc, Iztok Grabnar and David Drobne, Ustekinumab concentrations shortly after escalation to monthly dosing may identify endoscopic remission in refractory Crohn’s disease, European Journal of Gastroenterology & Hepatology 2021, DOI: 10.1097/MEG.0000000000002275.
13. 2021-Melissa Kotterman, Ghezal Beliakoff, Roxanne Croze, Tandis Vazin, Christopher Schmitt, Paul Szymanski, Meredith Leong, Melissa Quezada, Jenny Holt, Katherine Barglow, Mohammad Hassanipour, David Schaffer, Peter Francis, David Kirn, Directed Evolution of AAV Targeting Primate Retina by Intravitreal Injection Identifies R100, a Variant Demonstrating Robust Gene Delivery and Therapeutic Efficacy in Non-Human Primates, bioRxiv.  doi: https://doi.org/10.1101/2021.06.24.449775.
14. 2021-Aguiar Zdovc, J.; Hanžel, J.; Kurent, T.; Sever, N.; Koželj, M.; Smrekar, N.; Novak, G.; Štabuc, B.; Dreesen, E.; Thomas, D.; et al. Ustekinumab Dosing Individualization in Crohn’s Disease Guided by a Population Pharmacokinetic–Pharmacodynamic Model. Pharmaceutics 2021, 13, 1587. https://doi.org/10.3390/ pharmaceutics13101587.
15. 2021-Katarina Mitrova, Barbora Pipek , Martin Bortlik, Ludek Bouchner, Jan Brezina, Tomas Douda, Tomas Drasar, Pavel Drastich, Premysl Falt, Pavel Klvana, Vaclav Leksa, Ales Novotny, Pavel Svoboda, Jan Skorpik, Jan Ulbrych, Marek Veinfurt, Blanka Zborilova, Milan Lukas and Dana Duricova. Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study, Ther Adv Gastroenterol 2021, Vol. 14: 1–9,
16. 2021-Karin Cerna, Dana Duricova, Martin Lukas, Nadezda Machkova, Veronika Hruba, Katarina Mitrova, Kristyna Kubickova, Marta Kostrejova, Vladimir Teplan, Martin Vasatko, Kristyna Kastylova, and Milan Lukas, Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immunemodifying Therapy: Prospective Single-Tertiary Study, Inflammatory Bowel Diseases, 2021, XX, 1–7.https://doi.org/10.1093/ibd/izab301.
17. 2021-Rawan Charbaji, Mrityunjoy Kar, Loryn E. Theune, Julián Bergueiro, Anne Eichhorst, Lucila Navarro, Patrick Graff, Friederike Stumpff, Marcelo Calderón, and Sarah Hedtrich, Design and Testing of Efficient Mucus-Penetrating Nanogels—Pitfalls of Preclinical Testing and Lessons Learned, Small 2021, 17, 2007963, DOI: 10.1002/smll.202007963.
18. 2022-Jakkrit Juhong, Pear Ferreira Pongsachareonnont, Thanapong Somkijrungroj, Apivat Mavichak, Adisai Varadisai, Pajaree Chariyavilaskul, Tanittha Chatsuwan, Thitima Benjachat Suttichet & Kittisak Kulvichit, The sterility, stability and efficacy of repackaged ziv‑aflibercept for intravitreal administration, Nature-Scientific Reports, (2022) 12:2971, https://doi.org/10.1038/s41598-022-06831-2.
19. 2022-Utku Furuncuoglu, Aslı Vural, Alev Kural, Ismail Umut Onur, Fadime Ulviye Yigit, Serum vascular endothelial growth factor, insulin‑like growth factor‑1 and aflibercept levels in retinopathy of prematurity, Japanese Journal of Ophthalmology (2022) 66:151–158, https://doi.org/10.1007/s10384-021-00895-9.

POSTER PRESANTATIONS

1. 2019-Malíčková Karin, Bortlík Martin, Ďuricová Dana, Machková Naděžda, Hrubá Veronika, Lukáš Martin, Vašátko Martin, Mitrová Katarína, Kostrejová Marta and Lukáš Milan, Serum trough SB5 levels: A comparison of two different immunoassays for the monitoring of biosimilar adalimumab treatment in patients with inflammatory bowel disease, United European Gastroenterology, UEG-WEEK, 2019; October 19-23, Barcelona-SPAIN
2. 2019-Lukas M, Pesinova V, Bortlik M. Duricova D., Machkova N., Hruba V., Lukas M., Vasatko M., Malickova K., P1806 – Impact of the switch from original Adalimumab to biosimilar Adalimumab SB5 on serum drug trough levels, clinical and biological disease activity in patients with IBD, United European Gastroenterology, UEG-WEEK, 2019; October 19-23, Barcelona-SPAIN.
3. 2019-K. Pudilova, M. Kolar, D. Duricova, K. Malickova, V. Hruba, N. Machkova, R. Vanickova, K. Mitrova, M. Lukas, M. Vasatko, M. Lukas, M. Bortlik, Early vedolizumab trough levels are not associated with a short-term response in patients with inflammatory bowel disease, United European Gastroenterology, UEG-WEEK, 2019; October 19-23, Barcelona-SPAIN.
4. 2022-Orfanoudaki, M. Gazouli, E. Theodoraki, K. Foteinogiannopoulou, N.P. Andreou, I.E. Koutroubakis, The role of proactive measurement of adalimumab trough levels and antibodies to adalimumab in Greek patients with Inflammatory Bowel Disease, Abstract P478, Abstracts of the 17th Congress of ECCO – European Crohn’s and Colitis Organisation. Journal of Crohn’s and Colitis, Volume 16, Issue Supplement_1, January 2022, Pages i447–i448, https://doi.org/10.1093/ecco-jcc/jjab232.605